Quince Therapeutics (QNCX) Stock Price, Quote, News & History | Benzinga

Quince Therapeutics Inc (QNCX) Stock Price, Quote, News & History

QNCXNASDAQ

Trade with Public

Trade with Public

$33.93

1.825.67%

At close: Aug 21, 5:00 PM EST

$35.12

1.193.5%

After Hours: Aug 17, 9:11 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$32.77

Close

$33.93

Volume / Avg.

9.54K / 23.56K

Day Range

$32.57 - $34.09

52 Wk Range

15.10 - 18.20K

Market Cap

$35.72M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

5.58%

Days to Cover

1.52

Recent Quince Therapeutics, Inc. News

Dow Jumps Over 1,300 Points; Delta Air Lines Shares Gain After Q1 Results

US stocks rose, Dow up 2.85%, Nasdaq up 3.33%, S&P 500 up 2.54%. Consumer discretionary shares up 3.9%, energy stocks down 6.6%.

Avi Kapoor

Why Levi Strauss Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Levi Strauss (LEVI) reported strong Q1 2026 results, raising revenue & earnings guidance. Other pre-market gainers include QNCX, VSME, UCAR, IPW, JEM, AZI, GPUS, AXTI, IPX.

Avi Kapoor

What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours

Quince Therapeutics shares surged 53% after hours Thursday following the engagement of LifeSci Capital as financial advisor amid restructuring and strategic plans.

Mohd Haider

Quince Therapeutics Stock Plunges As Filing Shows Reverse Merger Plans, Bankruptcy Risks

Quince Therapeutics stock is trading sharply lower Thursday after the biotech company followed up Wednesday's rally with a Form 8-K that underscores how precarious its situation is.

Henry Khederian

Dow Jumps Over 200 Points; US Initial Jobless Claims Fall

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-46.92M

Investing Cash Flow (TTM)

26.29M

Financing Cash Flow (TTM)

121.79M

Free Cash Flow (TTM)

-47.00M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

101.15M

Analyst Trends and Forecast

2

Jun

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$81.92M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-645.17%

Earnings Yield % (FWD)

-24.48%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$34.73

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$115.98M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$32.77

Close

$33.93

Volume / Avg.

9.54K / 23.56K

Day Range

$32.57 - $34.09

52 Wk Range

15.10 - 18.20K

Market Cap

$35.72M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

5.58%

Days to Cover

1.52

About

Sector

Health Care

Industry

Biotechnology

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses a...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Quince Therapeutics (QNCX) stock?

A

You can purchase shares of Quince Therapeutics (NASDAQ:QNCX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Quince Therapeutics (QNCX) competitors?

A

Other companies in Quince Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Quince Therapeutics (QNCX) stock?

A

Quince Therapeutics has a consensus price target of $23.56.

Q

What is the current price for Quince Therapeutics (QNCX)?

A

The stock price for Quince Therapeutics (NASDAQ: QNCX) is $35.1188 last updated August 17, 2026 at 9:11 AM EDT.

Q

Does Quince Therapeutics (QNCX) pay a dividend?

A

There are no upcoming dividends for Quince Therapeutics.

Q

When is Quince Therapeutics (NASDAQ:QNCX) reporting earnings?

A

Quince Therapeutics does not have any upcoming earnings scheduled.

Q

Is Quince Therapeutics (QNCX) going to split?

A

There is no upcoming split for Quince Therapeutics.

Q

What sector and industry does Quince Therapeutics (QNCX) operate in?

A

Quince Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.